DANOY vs MICC: Which Is the Better Buy in 2026?
Last updated November 2026
Short answer
DANOY is the larger of the two ($48.44B market cap): the incumbent the market prices for continued execution (15.98x forward earnings, beta 0.16). MICC is the smaller challenger ($11.57B), priced similarly on forward earnings (15.92x): more room to run, but more to prove. If the story you believe is DANOY's (Health-focused portfolio and protein), DANOY is the more direct way to own it; if it is MICC's (Volume-led growth from the big brands), MICC is.
DANOY vs MICC: the tie-breaker metrics
Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | DANOY | MICC | What it tells you |
|---|---|---|---|
| Market cap | $48.44B | $11.57B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 15.98 | 15.92 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Trailing P/E | 21.49 | 39.11 | Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price. |
| Price vs 52-week range | 40% of range | 80% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 2.45 | 9.66 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Before you buy: how DANOY and MICC affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. DANOY and MICC share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined DANOY and MICC exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Danone S.A. (DANOY) do?
Danone S.A. is a Paris-based packaged food and beverage group with roughly €27 billion in annual sales, sold in more than 120 countries. It runs three businesses. Essential Dairy and Plant-Based is the largest, with brands such as Activia, Danone, Oikos, YoPRO, Silk, Alpro and International Delight coffee creamers. Specialized Nutrition covers infant formula (Aptamil, Nutrilon) and medical nutrition sold under Nutricia to hospitals, pharmacies and patients with specific dietary needs, and it is the group's highest-margin segment. Waters includes Evian, Volvic, Aqua in Indonesia and Mizone in China. Under CEO Antoine de Saint-Affrique, who took over in 2021 after a period of activist pressure and weak growth, Danone has pruned slower brands, exited Russia, and bought into faster-growing health niches: a majority stake in Kate Farms (plant-based tube-feeding and protein shakes), The Akkermansia Company (gut-health supplements) and, completed on September 4, 2026, Huel, the UK complete-nutrition brand bought for roughly €1 billion.
What does The Magnum Ice Cream Company (MICC) do?
The Magnum Ice Cream Company N.V. (MICC) is the world's largest ice cream maker, owning four of the five biggest ice cream brands: Magnum, Ben & Jerry's, Cornetto and the Heartbrand (sold as Wall's, Algida, Langnese, Ola, Kibon and others), plus Yasso, Breyers, Klondike and Popsicle in the US. Headquartered in Amsterdam, it sells in about 80 markets, runs 32 factories and roughly three million freezer cabinets, and employs about 18,000 people. Unilever demerged it in December 2025; it trades on Euronext Amsterdam, the London Stock Exchange and the NYSE, and reports in euros. Here, euro figures are converted at roughly $1.13 per euro, an approximate late-October 2026 rate used throughout.
DANOY vs MICC: how do they differ?
Both fit overlapping themes, but they are not interchangeable. Here is what each one depends on.
- DANOY drivers: Health-focused portfolio and protein; Specialized Nutrition recovery after the recall.
- MICC drivers: Volume-led growth from the big brands; The €500 million productivity programme.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: Product-safety events are the most acute risk for a company that sells infant formula and medical nutrition, as the 2026 recall showed: the ADR fell ~8% on January 21 and ~2.7% more two days later. For MICC, weather is the most direct risk: ice cream is seasonal and Magnum itself estimates an extended European summer added 2 to 3 points to Q3 growth, so 2027 faces tough comparisons if summers are cooler.
DANOY or MICC: which should you pick?
With growth, valuation and volatility this close (or not yet reported for one side), the drivers above are what separate DANOY from MICC. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the DANOY and MICC guides.
DANOY vs MICC: the full fundamentals
DANOY. At the November 20, 2026 close of $15.04 (equal to ~$75 per ordinary share), DANOY trades at about 16 times forward earnings and about 21.5 times trailing reported earnings, which were reduced by ~€725 million of non-recurring charges in 2025 that cut reported net income ~9.7% to ~€1.8 billion even as recurring net income rose ~5% to ~€2.5 billion. That sits at or slightly below large European staples peers such as Nestle and Unilever, and the ADR is about 19% below the mean target of four analysts (~$18.52). Free cash flow of ~€2.8 billion in 2025 covered the ~€1.5 billion dividend bill, leaving room for bolt-on deals like Huel and MADE Group.
MICC. Figures are approximate as of November 2026, reported in euros and converted at roughly $1.13 per euro. Trailing revenue combines full-year 2025 (~€7.9 billion) with the 2026 year-to-date change through Q3; trailing adjusted EBITDA runs through June 2026. Market value is Yahoo Finance's figure at the $19.17 close on November 20, 2026. Adjusted EPS for 2025 was ~€0.93 (~$1.05), implying roughly 18x trailing adjusted earnings, and about 16x consensus 2027 EPS. Magnum plans to pay out 40% to 60% of adjusted net income, with a first dividend expected in H1 2027.
Headline figures (approximate, November 2026): DANOY shows revenue (ttm) ~€27.5 billion; Q3 2026 sales ~€7.2 billion, like-for-like sales growth (h1 2026) ~3.5%; 2026 guidance of 3% to 5% confirmed in October, operating margin (ttm) ~13.5%; net margin ~7.1%, net income (ttm) ~€1.9 billion; MICC shows revenue (ttm) ~€8.4B (~$9.4B), adjusted ebitda (ttm) ~€1.28B (~$1.45B), market cap ~$11.6B, ev / adj. ebitda ~10.5x.
The bottom line: DANOY vs MICC
DANOY and MICC are related but distinct: same themes, different businesses and risks. Neither wins in the abstract, and whichever you pick is worth sizing so one theme does not take over your portfolio. Walnut can show your combined DANOY and MICC exposure against your real portfolio. It is not an investment adviser.
Wondering how DANOY or MICC fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Your questions about Danone S.A.
Ask Walnut's AI anything about DANOY and see how it fits what you own.
FAQ
What is the difference between DANOY and MICC?
+
Danone S.A. The Magnum Ice Cream Company N.V. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is DANOY or MICC the better stock?
+
Neither is universally better. DANOY is the larger incumbent; MICC is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, DANOY or MICC?
+
On forward P/E (as of November 2026), DANOY trades at 15.98x and MICC at 15.92x, so MICC is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both DANOY and MICC?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of DANOY vs MICC?
+
DANOY: Product-safety events are the most acute risk for a company that sells infant formula and medical nutrition, as the 2026 recall showed: the ADR fell ~8% on January 21 and ~2.7% more two days later. Several US plaintiff firms, including Rosen and Pomerantz, then announced investigations on behalf of DANOY holders, although no filed securities class action had surfaced in public reporting as of November 2026. China, a key market for formula and for Mizone water, faces a falling birth rate and a slower economy, while the Waters business is sensitive to weather, plastics regulation and scrutiny of mineral water treatment practices in France. Because DANOY is priced in dollars while Danone reports in euros, a stronger dollar lowers the ADR's value and its dividend even when the underlying business is unchanged, and currency already turned 2025's ~4.5% organic growth into a slight reported decline. Dividends are paid once a year and face French withholding tax (25% by default, reducible to the 15% treaty rate with paperwork), and the ADR trades over the counter with thinner volume and wider spreads than the Euronext Paris listing. MICC: Weather is the most direct risk: ice cream is seasonal and Magnum itself estimates an extended European summer added 2 to 3 points to Q3 growth, so 2027 faces tough comparisons if summers are cooler. Input costs are another: dairy, cocoa, sugar, packaging and especially energy (freezers and cold chain) feed straight into margins, and management named higher oil and energy prices as a 2026 headwind. Separation risk is real, with TSA exits and an IT transformation running through 2027. Leverage is moderate but not trivial, with net debt of ~€3.26 billion (~$3.7 billion), about 2.5x adjusted EBITDA at mid-2026. Ben & Jerry's carries brand and legal risk: a suit by former independent directors over the brand's social mission survived in part in August 2026, with Magnum as the main defendant. Türkiye, a large market, brings currency and regulatory volatility. Longer term, GLP-1 weight-loss drugs and health trends could weigh on indulgent treats. Unilever retained ~19.9% at the spin and plans to exit over time, a potential source of share supply, and a tax indemnity tied to the demerger complicates any takeover.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell DANOY or MICC; figures are approximate and dated (as of November 2026). Verify current data before investing.